AUAntonella Usticano

Antonella Usticano

*This is an algorithmically generated author record based on publicly available information.

Antonella Usticano has a total of 29 co-authors. Here are the top co-authors by number of shared publications:

  • Alessandra Allotta

    Department of Health Activities and Epidemiological Observatory of Sicily Region, Palermo, Italy

    1 shared publication
  • Alessandra Ravaioli

    Emilia-Romagna Cancer Registry, Romagna Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Forlì, Italy

    1 shared publication
  • Antonino Musolino

    Parma Cancer Registry, Medical Oncology Unit, Parma University Hospital, Parma, Italy

    1 shared publication
  • Antonio Craxì

    Section of Gastroenterology & Hepatology, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, PROMISE, University of Palermo, 90127 Palermo, Italy

    1 shared publication
  • Donatella Ferraro

    Microbiology Section, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties ‘G. D’Alessandro’, University of Palermo, 90133 Palermo, Italy

    1 shared publication
  • Emanuele Crocetti

    Romagna Cancer Registry, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Forlì, Italy

    1 shared publication

Latest Publications

  • North-south differences in incidence and surveillance of cutaneous malignant melanoma in Italy

    by Lauro Bucchi, Silvia Mancini, Federica Zamagni, Emanuele Crocetti, Luigino Dal Maso, Stefano Ferretti, Flavia Baldacchini, Orietta Giuliani, Alessandra Ravaioli, Rosa Vattiato, et al.

    Background: In Italy, the incidence of cutaneous malignant melanoma is two-fold higher in the north than in the south. This gradient might be associated with differences in incidence trends and disease surveillance. We compared the time trends in incidence rates, mortality rates, dermatologic office visit rates and skin biopsy rates between the Emilia-Romagna Region (northern Italy) and the Sicily Region (southern Italy). Methods: The cancer registries of Parma, Modena, Ferrara and Romagna (current population, 2,606,465) and Catania-Messina-Enna, Siracusa and Ragusa (2,775,019) provided incidence and mortality records for the years 2008-2017. The records of outpatient services delivered in public health facilities were obtained from the two Regional Administrations. Trends in rates were assessed with the estimated average annual percent change. North-south differences were expressed as age-standardised rate ratios. Results: In the context of a generalised increasing incidence trend, which was more moderate in the female population of the Sicily Region, the standardised rate ratios were: 5.31 (males) and 5.20 (females) for in situ cutaneous malignant melanoma; 2.10 and 2.07 for invasive cutaneous malignant melanoma, with an excess incidence concentrated in lesions ⩽1.00 mm thick (3.58 and 3.05); 3.00 and 2.44 for dermatologic office visits; and 5.25 and 5.02 for skin biopsies. Mortality was stable in both Regions. Conclusions: In the Emilia-Romagna Region, as compared with the Sicily Region, a higher incidence of cutaneous malignant melanoma –especially of in situ and early invasive cutaneous malignant melanoma– coexisted with a higher level of clinical surveillance. The question of the direction of the cause-effect relationship between increased incidence and increased diagnostic scrutiny remains open.


  • Endemic hepatitis C virus infection in a Sicilian town: Further evidence for iatrogenic transmission

    by Rosa Di Stefano, Tommaso Stroffolini, Donatella Ferraro, Antonella Usticano, Lilli Mario Valenza, Luigi Montalbano, Giuseppina Pomara, Antonio Craxì

    The prevalence of and risk factors for HCV and HBV infections in the general population and the predictive value of ALT screening in identifying anti‐HCV positive subjects have been evaluated in a small Sicilian town. A random 1:4 sampling from the census of the general population was performed. Anti‐HCV, HCV‐RNA, HCV genotype, HBsAg, and anti‐HBc were tested. The linkage between HCV infection and potential risk factors was evaluated by multiple logistic regression analysis. Among 721 subjects studied, 75 (10.4%) were anti‐HCV positive. The HCV infection rate increased from 0.4% in subjects 10–29 years of age to 34% in those > 60 years of age. Among the 75 anti‐HCV positive subjects, 66.7% were HCV‐RNA positive and 36% had abnormal ALT, in contrast abnormal ALT levels were found in 4.3% of the 646 anti‐HCV negative subjects (P < 0.01). HCV genotype 1b infected the majority (88.0%) of viremic subjects. Exposure to HBV infection (anti‐HBc positivity) was found in 11.2% of subjects; HBsAg positivity was 0.7%. At multivariate analysis, two variables were associated with HCV infection: age ≥ 45 years (OR 27.8; CI 95% = 11.0–70.2) and previous hospitalization (OR 2.5; CI 95% = 1.3–4.7). ALT testing had low positive predictive value (PPV = 49.1%) for HCV infection. The positive predictive value was good (88%) in people ≥ 60 years of age, but minimal (16.7%) in those below 60. These findings indicate that HCV infection is common in the elderly, perhaps as a result of past iatrogenic transmission. The present low rate of HCV infection among the younger generations coupled with the low progression of the viral related liver damage does not support the projection of a future increasing incidence in the next decades of the burden of HCV‐related chronic disease. HBV infection, formerly common in this area, is already in sharp decline. In an area of high HCV endemicity, screening of the general population by ALT cannot be used a surrogate marker to detect HCV infection in those susceptible to treatment. J. Med Virol. 67:339–344, 2002.